These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 28542030)

  • 1. Predictors of poor clinical outcomes after successful chronic total occlusion intervention with drug-eluting stents.
    Kim GS; Kim BK; Shin DH; Kim JS; Hong MK; Gwon HC; Kim HS; Yu CW; Park HS; Chae IH; Rha SW; Jang Y;
    Coron Artery Dis; 2017 Aug; 28(5):381-386. PubMed ID: 28542030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Full Metal Jacket With Drug-Eluting Stents for Coronary Chronic Total Occlusion.
    Lee PH; Lee SW; Yun SC; Bae J; Ahn JM; Park DW; Kang SJ; Kim YH; Lee CW; Park SW; Park SJ
    JACC Cardiovasc Interv; 2017 Jul; 10(14):1405-1412. PubMed ID: 28668311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Procedural and Long-Term Outcomes of Bioresorbable Scaffolds Versus Drug-Eluting Stents in Chronic Total Occlusions: The BONITO Registry (Bioresorbable Scaffolds Versus Drug-Eluting Stents in Chronic Total Occlusions).
    Azzalini L; Giustino G; Ojeda S; Serra A; La Manna A; Ly HQ; Bellini B; Benincasa S; Chavarría J; Gheorghe LL; Longo G; Miccichè E; D'Agosta G; Picard F; Pan M; Tamburino C; Latib A; Carlino M; Chieffo A; Colombo A
    Circ Cardiovasc Interv; 2016 Oct; 9(10):. PubMed ID: 27765802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term clinical outcomes of successful versus unsuccessful revascularization with drug-eluting stents for true chronic total occlusion.
    Lee SW; Lee JY; Park DW; Kim YH; Yun SC; Kim WJ; Suh J; Cho YH; Lee NH; Kang SJ; Lee CW; Park SW; Park SJ
    Catheter Cardiovasc Interv; 2011 Sep; 78(3):346-53. PubMed ID: 21452248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence, predicting factors, and clinical outcomes of periprocedural myocardial infarction after percutaneous coronary intervention for chronic total occlusion in the era of new-generation drug-eluting stents.
    Kim JH; Kim BK; Kim S; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
    Catheter Cardiovasc Interv; 2018 Sep; 92(3):477-485. PubMed ID: 29266736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful Recanalization of Native Coronary Chronic Total Occlusion Is Not Associated With Improved Long-Term Survival.
    Lee PH; Lee SW; Park HS; Kang SH; Bae BJ; Chang M; Roh JH; Yoon SH; Ahn JM; Park DW; Kang SJ; Kim YH; Lee CW; Park SW; Park SJ
    JACC Cardiovasc Interv; 2016 Mar; 9(6):530-8. PubMed ID: 26947387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and Effectiveness of Everolimus-Eluting Stents in Chronic Total Coronary Occlusion Revascularization: Results From the EXPERT CTO Multicenter Trial (Evaluation of the XIENCE Coronary Stent, Performance, and Technique in Chronic Total Occlusions).
    Kandzari DE; Kini AS; Karmpaliotis D; Moses JW; Tummala PE; Grantham JA; Orr C; Lombardi W; Nicholson WJ; Lembo NJ; Popma JJ; Wang J; Larracas C; Rutledge DR
    JACC Cardiovasc Interv; 2015 May; 8(6):761-769. PubMed ID: 25912400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late-term safety and effectiveness of everolimus-eluting stents in chronic total coronary occlusion revascularization: Final 4-year results from the evaluation of the XIENCE coronary stent, Performance, and Technique in Chronic Total Occlusions (EXPERT CTO) multicenter trial.
    Kandzari DE; Karmpaliotis D; Kini AS; Moses JW; Tummala PE; Grantham JA; Orr C; Lombardi W; Nicholson WJ; Lembo NJ; Popma JJ; Wang J; Zhao W; McGreevy R
    Catheter Cardiovasc Interv; 2019 Oct; 94(4):509-515. PubMed ID: 31444897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival after percutaneous coronary intervention for chronic total occlusion.
    Toma A; Gick M; Minners J; Ferenc M; Valina C; Löffelhardt N; Gebhard C; Riede F; Neumann FJ; Buettner HJ
    Clin Res Cardiol; 2016 Nov; 105(11):921-929. PubMed ID: 27250096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in patients with coronary artery disease: final 5-year report of the LEADERS (Limus Eluted From A Durable Versus ERodable Stent Coating) randomized, noninferiority trial.
    Serruys PW; Farooq V; Kalesan B; de Vries T; Buszman P; Linke A; Ischinger T; Klauss V; Eberli F; Wijns W; Morice MC; Di Mario C; Corti R; Antoni D; Sohn HY; Eerdmans P; Rademaker-Havinga T; van Es GA; Meier B; Jüni P; Windecker S
    JACC Cardiovasc Interv; 2013 Aug; 6(8):777-89. PubMed ID: 23968698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous intervention in chronic total coronary occlusions caused by in-stent restenosis: procedural results and long-term clinical outcomes in the TORO (Spanish registry of chronic TOtal occlusion secondary to an occlusive in-stent RestenOsis) multicentre registry.
    de la Torre Hernandez JM; Rumoroso JR; Subinas A; Gonzalo N; Ojeda S; Pan M; Martín Yuste V; Suárez A; Hernández F; Teruel L; Moreu J; Cubero JM; Cascón JD; Vinhas H; Lozano Í; Martin Moreiras J; Pérez de Prado A; Goicolea J; Escaned J
    EuroIntervention; 2017 Jun; 13(2):e219-e226. PubMed ID: 27993757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Procedural and Long-Term Outcomes of Percutaneous Coronary Intervention for In-Stent Chronic Total Occlusion.
    Azzalini L; Dautov R; Ojeda S; Benincasa S; Bellini B; Giannini F; Chavarría J; Pan M; Carlino M; Colombo A; Rinfret S
    JACC Cardiovasc Interv; 2017 May; 10(9):892-902. PubMed ID: 28412256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Major Predictors of Long-Term Clinical Outcomes After Percutaneous Coronary Intervention for Coronary Bifurcation Lesions With 2-Stent Strategy: Patient-Level Analysis of the Korean Bifurcation Pooled Cohorts.
    Song PS; Song YB; Lee JM; Hahn JY; Choi SH; Choi JH; Lee SH; Park KW; Kim HS; Jang Y; Seung KB; Oh JH; Gwon HC
    JACC Cardiovasc Interv; 2016 Sep; 9(18):1879-86. PubMed ID: 27592016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcome of percutaneous coronary intervention for chronic total occlusions.
    Mehran R; Claessen BE; Godino C; Dangas GD; Obunai K; Kanwal S; Carlino M; Henriques JP; Di Mario C; Kim YH; Park SJ; Stone GW; Leon MB; Moses JW; Colombo A;
    JACC Cardiovasc Interv; 2011 Sep; 4(9):952-61. PubMed ID: 21939934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: final 3-year results of the SPIRIT clinical trials program (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
    Dangas GD; Serruys PW; Kereiakes DJ; Hermiller J; Rizvi A; Newman W; Sudhir K; Smith RS; Cao S; Theodoropoulos K; Cutlip DE; Lansky AJ; Stone GW
    JACC Cardiovasc Interv; 2013 Sep; 6(9):914-22. PubMed ID: 24050859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Five-year clinical outcomes in patients with diabetes mellitus treated with polymer-free sirolimus- and probucol-eluting stents versus second-generation zotarolimus-eluting stents: a subgroup analysis of a randomized controlled trial.
    Harada Y; Colleran R; Kufner S; Giacoppo D; Rheude T; Michel J; Cassese S; Ibrahim T; Laugwitz KL; Kastrati A; Byrne RA;
    Cardiovasc Diabetol; 2016 Sep; 15(1):124. PubMed ID: 27586678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three-year clinical outcome after treatment of chronic total occlusions with second-generation drug-eluting stents in the TWENTE trial.
    van Houwelingen KG; Sen H; Lam MK; Tandjung K; Löwik MM; de Man FH; Louwerenburg JH; Stoel MG; Hartmann M; Linssen GC; Doggen CJ; von Birgelen C
    Catheter Cardiovasc Interv; 2015 Feb; 85(3):E76-82. PubMed ID: 25339110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Everolimus-eluting Xience v/Promus versus zotarolimus-eluting resolute stents in patients with diabetes mellitus.
    Park KW; Lee JM; Kang SH; Ahn HS; Kang HJ; Koo BK; Rhew JY; Hwang SH; Lee SY; Kang TS; Kwak CH; Hong BK; Yu CW; Seong IW; Ahn T; Lee HC; Lim SW; Kim HS
    JACC Cardiovasc Interv; 2014 May; 7(5):471-81. PubMed ID: 24852802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The anatomic- and clinical-based NERS (new risk stratification) score II to predict clinical outcomes after stenting unprotected left main coronary artery disease: results from a multicenter, prospective, registry study.
    Chen SL; Han YL; Zhang YJ; Ye F; Liu HW; Zhang JJ; Xu B; Jiang TM; Zhou YJ; Lv SZ
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1233-41. PubMed ID: 24239199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlates and outcomes related to periprocedural myocardial injury during percutaneous coronary intervention for chronic total occlusion: Results from a prospective, single center PCI registry.
    Zhang Q; Hu J; Yang ZK; Ding FH; Zhang JS; Du R; Zhu TQ; Shen WF; Kirtane AJ; Zhang RY
    Catheter Cardiovasc Interv; 2016 Mar; 87 Suppl 1():616-23. PubMed ID: 26864270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.